Leading Surgeon Allen Fonseca Uses Proove Narcotic Risk Genetic Tests To Improve Pain Treatment
Dr. Allen Fonseca has ordered over 300 Proove Bioscience Narcotic Risk tests in the last 9 months with success improving prescribing practices
9 May 2012
LOS ANGELES, CA (May 9, 2012) – Proove Biosciences, the leader in personalized pain medicine innovation, announces today that Dr. Allen S. Fonseca has been successfully utilizing its Proove Narcotic Risk test for over 9 months to improve the selection, dosing, and evaluation of prescription pain medications. One of southern California’s leading orthopedic surgeons, Fonseca has ordered the Proove Narcotic Risk test on over 300 patients to evaluate their predisposition for prescription pain medication tolerance, dependence, or potential abuse.
Proove Biosciences CEO Brian Meshkin states, “We are proud of our association with Dr. Fonseca, and look forward to continuing our work together.” Fonseca is an orthopedic surgeon and qualified medical evaluator (QME). His ASF Orthopedic Medical Group has offices in Whittier, Los Angeles, Bakersfield, San Bernardino, and Long Beach, California. Dr. Fonseca is board certified by the American College of Orthopedic Surgery, a fellow with the American Academy of Orthopedic Surgeons, North American Spine Society, Association of Veterans’ Administration Physicians, California Orthopedic Association, and Orange County Medical Association.